MediTox

… You develop the ideas, we can help you navigate through challenges of preclinical research

Our focus

MediTox is a GLP-certified CRO with more than 25 years’ experience in preclinical toxicology and extensive experience with variety of compounds and therapeutic areas, capable to conduct studies in full compliance with GLP standards and other international guidelines (EMA/ICH, VICH, OECD, FDA, ISO10993), providing core range of nonclinical studies enabling IND/registration for human drugs, biologicals and safety (TAS/BEQ/efficacy) studies for registration of veterinary drugs.
One of the few facilities in Europe using cats as target animals for the testing of veterinary drugs.

Whether you are just starting out or dealing with a specific issue, we are ready to discuss everything with you and propose a set of studies.
Quality
Compliance with OECD TG, EMA/ICH, VICH, ISO 10993
Human health
Compliance with OECD TG, EMA/ICH, EFSA, ISO 10993
Animal health
Compliance with VICH, EFSA
Medical device
Compliance with OECD TG, ISO 10993

Mission & vision

We are dedicated to being a reliable partner for our clients in bringing innovative ideas to market, with unwavering adherence to scientific integrity and business ethics.

Our goal is to be recognized as a trusted and respected partner in the field of drug development — known for our strong team of top-tier experts, high professional standards, flexibility, and a personalized, friendly approach to every client.

We strive for excellence in both operations and service by expertise. Through close collaboration with the scientific community, we ensure the highest quality of our services and continually work to enhance client satisfaction.

Key Highlights

  • Extensive expertise in non-rodent toxicology
  • Validated models for human diseases, including influenza, chronic glaucoma, osteoarthritis
  • One of the few facilities in Europe offering TAS and bioequivalence studies in cats
  • Dedicated team of experts specialized in advanced veterinary surgical procedures
  • Trusted research partner in multiple awarded European grant projects

Our team

Board of Directors

Expert Team

Business Development

News & Events

A study report is not the end of a project.

For sponsors, the final report often marks the beginning of the next milestone. - Regulatory submissions. - Scientific discussions. - Go/no-go decisions. - Planning the next study. That's why clarity matters. A well-written report doesn't simply present data—it explains the findings, provides scientific context, and allows confident decision-making. The value of a study is measured not only by how it was conducted, but also by how well its results can be understood.

Let’s meet at NLSDays 2026!

Visit MeditTox at NLS Days 2026 MediTox s.r.o. is pleased to once again participate in NLS Days 2026 as a long-standing exhibitor. We warmly invite you to visit us at Booth I:36, where our team will be happy to discuss your preclinical research needs, present our services, and explore opportunities for future collaboration. J. Novakova, Chief Operating Officer, and V. Maminakova, Project Manager, will be delighted to discuss your research needs, ideas, and potential collaboration opportunities.

The Czech Republic Pavilion was officially opened yesterday at the BIO International Convention in San Diego. We're proud that MediTox is once again part of this outstanding event and look forward to meeting partners, colleagues, and new contacts throughout the week.

Address

MediTox s.r.o.,
Pod Zámkem 279,
281 25 Konárovice, Czech Republic

company ID

25926713

vat number

CZ25926713
Would you like to ask a question? Contact us:
By submitting the form, you agree to the processing of your personal data.

Curriculum vitae

Načítám životopis…